Which companies make generic lamotrigine?
Generic lamotrigine is marketed by many manufacturers across different countries. Commonly, you’ll see products from large global generics companies (and their regional subsidiaries) and from local Indian/European generic brands. Examples of firms that have been associated with generic lamotrigine supply include Teva, Mylan/Viatris, Sandoz, Hikma, Accord, Lupin, Glenmark, Cipla, Dr. Reddy’s, Sun Pharma, and others—availability depends heavily on the country and the specific tablet strength (e.g., 25 mg, 100 mg).
Because manufacturers vary by market, the most reliable way to identify the exact “who makes it” for your prescription is to check your local pharmacy label for the brand/generic name and the manufacturer listed on the package.
How to find the exact generic manufacturer for your lamotrigine prescription
If you want the specific manufacturer tied to the product you received, look for:
- The product/brand name on the prescription label (even for generics, brands differ).
- The “manufacturer” or “marketed by” line on the box/blister pack.
- The strength and dosage form (immediate-release vs extended-release, if applicable in your region).
A quick search using the exact brand name plus your country usually returns the correct manufacturer and product listing.
Is generic lamotrigine interchangeable between brands?
Generic medicines are expected to match the reference product’s active ingredient (lamotrigine), strength, dosage form, and bioequivalence requirements. In practice, switching between brands is often possible, but people with epilepsy or other lamotrigine indications may be sensitive to changes in exposure, so prescribers sometimes specify “no substitution” or recommend careful monitoring when switching.
If you tell me your country and the dose/brand on the box, I can help you narrow down likely manufacturer listings for that exact product.
What to watch for when switching generic lamotrigine
Patients and clinicians commonly pay attention to:
- Seizure control (any change after a switch)
- Side effects (e.g., dizziness, headache, rash)
- Adherence and titration schedule consistency (lamotrigine dosing is often carefully escalated)
If you share what you’re switching from/to, I can outline the typical issues to discuss with the prescriber.
Do lamotrigine generics have different approval pathways or forms?
Generic availability depends on regional regulatory decisions and whether the product is:
- Immediate-release tablets vs other formulations
- Different strengths packaged for titration schedules
If you share your country and whether you use tablets (and the strength), I can tailor the answer to the relevant product types sold there.
Sources used
I don’t have any manufacturer-specific sources in the provided material to cite accurately. If you share your country (and the brand name or strength), I can give a more precise, source-backed list of manufacturers that are actually sold there.